Asymptomatic Infections: Clinical Trials

4 trials for Asymptomatic Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Recruiting 1
Phase 11Recruiting 1

Follow Asymptomatic Infections: new trials by email Literature Review of Asymptomatic Infections trials Research Report on Asymptomatic Infections

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization
Resistant Potato Starch, Maltodextrin - Clostridium Infections, Methicillin-resistant Staphylococcus Aureus (MRSA)
Phase 2Not yet recruitingVA Office of Research and Development1202027-01-012026-08-28
Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization
lyophilized FMT capsules, Placebo capsules - Colonization, Asymptomatic
Phase 1 / Phase 2RecruitingUniversity of Rijeka522025-07-282026-10-27
Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)
M5717 60 mg, Pyronaridine, Atovaquone-Proguanil - Malaria Infection
Phase 2CompletedMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1922023-11-282026-02-06
A Randomized Control Trial of Antibiotic Treatment Duration For Asymptomatic Bacteriuria After Kidney Transplantation
7 days course of antibiotic treatment, 14 days course of antibiotic treatment - Kidney Transplantation, Bacteriuria
Phase 2CompletedMahidol University202015-02-012016-03-16

Narrower conditions

Bacteriuria (1)  ·  Clostridium Infections (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)

Broader conditions

Asymptomatic Diseases (4)  ·  Disease Attributes (4)  ·  Infections (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Male Urogenital Diseases (1)  ·  Mosquito-Borne Diseases (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Urinary Tract Infections (1)

Interventions

atovaquone, proguanil drug combination (1)  ·  maltodextrin (1)  ·  pyronaridine (1)

Sponsors

Mahidol University (1)  ·  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)  ·  University of Rijeka (1)  ·  VA Office of Research and Development (1)

Countries

Burkina Faso (1)  ·  Croatia (1)  ·  Kenya (1)  ·  Thailand (1)  ·  The Gambia (1)  ·  United States (1)  ·  Zambia (1)

Top investigators

Nasia Safdar, MD PhD (1)  ·  Pattraporn Ponglorpisit, MD (1)

Results publications

PMID 42665356